Vien Dong Pharmaceutical JSC - Company Capsule

Document Sample
Vien Dong Pharmaceutical JSC - Company Capsule Powered By Docstoc
					Vien Dong Pharmaceutical JSC

_________________________________________________________________________________



Vien Dong Pharmaceutical JSC                                    Financial Snapshot

                                                                Operating Performance
Fast Facts
                                                                The company reported revenue of US$50.94 million
Headquarters Address            No. 411, Phu Nhuan, ,Vietnam
                                                                during the fiscal year 2009 (2009), an increase of
                                                                32.28% over 2008. In 2009, the company recorded an
Telephone                       + 84 8 39910866
                                                                operating margin of 14.89%, as against 5.53% in
                                                                2008.
Fax                             + 84 8 39910867

Website                         N/A                             Revenue and Margins

Ticker Symbol, Stock Exchange   DVD, Hochiminh Stock Exchange

Number of Employees             646

Fiscal Year End                 December

Revenue (in US$ million)        50.94

Revenue (in VND million)        917,186.31




                                                                Return on Equity

                                                                The company recorded a return on equity (ROE) of
                                                                25.39% for 2009, as compared to its peers, DHG
                                                                Pharmaceutical   JSC    (Ticker:  DHG),    Hatay
                                                                Pharmaceutical JSC (Ticker: DHT) and Imexpharm
                                                                Pharmaceutical JSC (Ticker: IMP), which recorded
                                                                ROEs of 35.07%, 16.48% and 12.22% respectively.
                                                                The company reported an operating margin of
                                                                14.89% in 2009.


                                                                Return on Equity




                                                                Liquidity Position

                                                                The company reported a current ratio of 2.02 in 2009,
                                                                as compared to its peers, DHG Pharmaceutical JSC,
                                                                Hatay Pharmaceutical JSC and Imexpharm
                                                                Pharmaceutical JSC, which recorded current ratios of
                                                                2.74, 1.34 and 2.88 respectively. As of December
                                                                2009, the company recorded cash and short-term
                                                                investments of worth US$5.67 million, against
                                                                US$0.01 million current debt. The company reported
                                                                a debt to equity ratio of 0.37 in 2009 as compared to
                                                                its peers, DHG Pharmaceutical JSC, Hatay
                                                                Pharmaceutical JSC and Imexpharm Pharmaceutical
                                                                JSC, which recorded debt to equity ratios of 0.07,
                                                                1.37 and 0.07 respectively.




___________________________________________________________________________________________

Vien Dong Pharmaceutical JSC - Company Capsule                                                         Page 1
Vien Dong Pharmaceutical JSC

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 5
    1.1       Company Overview ................................................................................................................................................5
    1.2       Major Products and Services .................................................................................................................................5
2     Analysis of Key Performance Indicators ............................................................................................... 6
    2.1       Five Year Sna
				
DOCUMENT INFO
Description: Canadean's "Vien Dong Pharmaceutical JSC - Company Capsule" contains a company overview, key facts, key employees, products and services, locations and subsidiaries as well as financial ratios.
BUY THIS DOCUMENT NOW PRICE: $99 100% MONEY BACK GUARANTEED
PARTNER Canadean
Canadean has long held a reputation with FMCG markets for providing specialist business information by conducting detailed industry and consumer research, supported by insightful value-added analysis. We cover the entire spectrum of the consumer value chain from suppliers, brand owners, distribution channels and consumer insight. By researching markets in a holistic way, Canadean’s research methodology enables clients to make informed strategical decisions that are founded on robust and reliable data and market insights. We specialise in online survey panels, qualitative and quantitative in-country research, industry analysis and consultancy. Canadean’s dedicated in-country researchers and analysts have an industry background in marketing, market research, consulting and advanced statistical expertise. They are well positioned in the industries themselves and therefore, best placed to ask the right questions of the right people. This network of professional researchers stretches across more than 80 countries, enabling Canadean to conduct unique research via our trusted business communities.